CRISPR Gene Editing Market Size is projected to reach USD 14.80 Billion by 2030, growing at a CAGR of 29.80%: Straits Research

New York, United States, Aug. 01, 2022 (GLOBE NEWSWIRE) -- CRISPR Gene Editing, also called genome editing, modifies an organism's DNA. This method replaces, adds, or removes genetic material from the genome. As a result, the industry has developed many editing procedures. Gene editing treats and prevents diseases like cystic fibrosis, sickle cell disease, HIV, and cancer.

Genome engineering's progress has impacted healthcare and life science businesses. The amazing efficacy of CRISPR-Cas9 for genome editing has led to significant investments in genome engineering. Before clinical use, each variant's pros and cons must be weighed. Researchers are trying to overcome CRISPR's limitations to improve results. CRISPR gene editing holds incredible promise for changing human genomes and diseases. Ethical and societal issues arise.

Research organizations, pharmaceutical and biotechnology companies, and institutions seek more efficient genome editing techniques to increase specificity, cost-effectiveness, turnaround time, and human errors. Genome editing methods have evolved for biotech and agriculture. Simple, efficient, cost-effective, multiplex, high-throughput technologies. Demand for CRISPR gene editing will rise due to ageing, cancer, and genetic defects.

Get a Free Sample Copy of This Report @ https://straitsresearch.com/report/crispr-gene-editing-market/request-sample  

Global CRISPR Gene Editing Market: DRIVERS

• Genetic Research Will Grow the Market

Increased Genetic Research funding in industrialized places like North America will boost CRISPR's rise. Many U.S. government agencies created novel materials, equipment, and procedures for the public good. Government financing develops and manufactures rare genetic disease treatments. NHGRI funds genomes research (NHGRI).

National Institutes of Health (NIH), a U.S. medical research body, conducts genetic and biological research. In 2021, the NIH will provide Arizona State University and Bayer College of Medicine $1.6 million to test human genome editing. New solutions for genetic illnesses should enhance CRISPR gene editing market growth.

• Chronic Diseases Are Spreading

One in three people have chronic illnesses. Chronic diseases damage many people's health and well-being. This technology is CRISPR. CRISPR is a strong gene-editing tool. CRISPR helps with Huntington's, muscular dystrophy, cancer, and cholesterol. NORD reports the diagnostic rate for Duchenne Muscular Dystrophy in 2021. (DMD). Duchenne Muscular Dystrophy affects 3,500 male infants worldwide (DMD). Rising disposable income, chronic disease prevalence, and lifestyle changes will all boost the global CRISPR gene editing business.

Global CRISPR Gene Editing Market: KEY FUTURE OPPORTUNITIES

• Gene Editing Offers Huge Market Growth Potential

Contract research organizations (CROs), biotechnology and pharmaceutical companies, and research institutes make up the market. Biotech and pharmaceutical businesses held 45.5% of the market in 2021. Biotechnology companies' efforts on developing novel gene editing tools will enhance segmental growth. Horizon Discovery wanted to develop a genome-editing technique that produced precise and effective functioning genes. The company's products include the Modify-R algorithm CRISPR guide RNAs, which can modify the targeted gene. In recent years, technological advances have allowed market participants to produce viable gene editing tools for hereditary disorders.

Report Scope

Buy Now Full Report @ https://straitsresearch.com/buy-now/crispr-gene-editing-market

Regional Overview of Global CRISPR Gene Editing Market

North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa make up the CRISPR Gene Editing Market.

North America dominated the worldwide CRISPR gene editing market due to pharmaceutical and biotech investments, improved healthcare infrastructure, increased per capita income, and state-of-the-art research facilities and institutions. Due to the rise of rare illnesses in the US and Canada, North America accounted for 38% of the market in 2021 and is expected to grow significantly in the coming years. National Institutes of Health: 7,000 rare diseases affect 25-30 million Americans (NIH). As new gene editing methods and technologies become accessible, demand for rare disease medications soars.

North America is predicted to lead in 2030. Government and private funding, major pharma and gene therapy enterprises, and CRISPR use all contribute. CRISPR-edited crops are not considered GMOs in the U.S., prompting agricultural corporations to embark on commercialization.

Asia-Pacific CRISPR gene editing market at $1.1 billion in 2021. Increasing research groups in emerging countries will benefit regional industry. Major firms' focus on gene editing technology should stimulate regional growth. Asia-Pacific has the fastest-growing bioscience market. This is due to increased government funding for biotechnology to improve disease treatment. China, Japan, and India's R&D expansion will also drive regional market trends.

Key Highlights

• The global CRISPR Gene Editing Market was valued USD 1.09 billion in 2021 and is predicted to reach USD 14.80 billion by 2030, increasing at a CAGR of 29.80% from 2022 to 2030.
• By product type, the Global CRISPR Gene Editing Market is divided into CRISPR Products and Services. CRISPR Products include Kits and Enzymes (Vector-Based Cas9 and DNA-Free Cas9), Libraries, Design Tools, Antibodies, and Other Products (CRISPR/Cas9 plasmids, CRISPR Controls, and CRISPR RNAs). gRNA Design and Vector Construction, Cell Line and Engineering, Screening Services, and Other Services are CRISPR Services (Mediated Transcriptome Editing, and Epigenome Editing Services).
• By application, the global CRISPR gene editing market is divided into agricultural, biomedical (including gene therapy, drug discovery, and diagnostics), industrial, and other applications such as GM foods, biofuel, and animal breeding.
• By End-User, the segments include academic institutes and research centres, biotechnology companies, contract research organisations (CROs), and pharmaceutical and biopharmaceutical companies. Biotechnology and pharmaceutical/biopharmaceutical companies are the most important end-users.
• By region, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa make up the Global CRISPR Gene Editing Market. North America dominated the global share.

Get a Free Sample Copy of This Report @ https://straitsresearch.com/report/crispr-gene-editing-market/request-sample

List of Major Competitor Companies in the CRISPR Gene Editing Market Across the Globe Are

• CRISPR Therapeutics AG
• Thermo Fisher Scientific, Inc.
• Synthego Corporation
• System Biosciences LLC
• ToolGen, Inc.
• Agilent Technologies, Inc.
• GeneCopoeia, Inc.
• Horizon Discovery Group PLC
• Abcam, Inc.
• Applied StemCell, Inc.
• Cellecta, Inc.
• Integrated DNA Technologies, Inc.
• Merck KGaA
• New England Biolabs, Inc.
• Rockland Immunochemicals, Inc.

Global CRISPR Gene Editing Market: Segmentation

BY PRODUCT TYPE

• CRISPR Products
  • Kits and Enzymes (Vector-Based Cas9, and DNA-Free Cas9)
  • Libraries
  • Design Tools, Antibodies
  • Other Products (CRISPR/Cas9 plasmids, CRISPR Controls, and CRISPR RNAs)
• CRISPR Services
  • gRNA Design and Vector Construction
  • Cell Line and Engineering
  • Screening Services
  • Other Services (Mediated Transcriptome Editing, and Epigenome Editing Services)

BY APPLICATION

• Agricultural
• Biomedical (Gene Therapy, Drug Discovery, And Diagnostics)
• Industrial
• Other Applications [Genetically Modified Foods (GM Foods), Biofuel, And Animal (Livestock) Breeding]

BY END-USER

• Academic Institutes and Research Centres
• Biotechnology Companies
• Contract Research Organizations (CROs)
• Pharmaceutical and Biopharmaceutical Companies

BY GEOGRAPHY

• North America
• Europe
• Asia Pacific (APAC)
• Latin America
• Middle East and Africa (MEA)

TABLE OF CONTENT

1. Introduction
   1. Market Definition
   2. Market Scope
2. Research Methodology
   1. Primary Research
   2. Research Methodology
   3. Assumptions & Exclusions
   4. Secondary Data Sources
3. Market Overview
   1. Report Segmentation & Scope
   2. Value Chain Analysis: CRISPR Gene Editing Market
   3. Key Market Trends
      1. Drivers
      2. Restraints
      3. Opportunities
   4. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitution
      4. Threat of New Entrants
      5. Competitive Rivalry
   5. Market Share Analysis
4. Product Type Overview
   1. Introduction
      1. Market Size & Forecast
   2. CRISPR Products
      1. Market Size & Forecast
   3. CRISPR Services
      1. Market Size & Forecast
5. Applications Overview
   1. Introduction
      1. Market Size & Forecast
   2. Agricultural
      1. Market Size & Forecast
   3. Biomedical
      1. Market Size & Forecast
6. Regional Overview
   1. Introduction
      1. Market Size & Forecast
   2. America
      1. North America
      2. U.S.
         1. By Product Type
         2. By Applications
      3. Canada
         1. By Product Type
         2. By Applications
      4. Mexico
         1. By Product Type
         2. By Applications
      5. Latin America
         1. By Product Type
         2. By Applications
   3. Europe
      1. Market Size & Forecast
      2. Germany
         1. By Product Type
         2. By Applications
      3. France
         1. By Product Type
         2. By Applications
      4. U.K.
         1. By Product Type
         2. By Applications
      5. Italy
         1. By Product Type
         2. By Applications
      6. Spain
         1. By Product Type
         2. By Applications
      7. Rest of Europe
         1. By Product Type
         2. By Applications
   4. Asia Pacific
      1. Market Size & Forecast
      2. Japan
         1. By Product Type
         2. By Applications
      3. China
         1. By Product Type
         2. By Applications
      4. Australia
         1. By Product Type
         2. By Applications
      5. India
         1. By Product Type
         2. By Applications
      6. South Korea
         1. By Product Type
         2. By Applications
      7. Rest of Asia-Pacific
         1. By Product Type
         2. By Applications
   5. Middle East & Africa
      1. Market Size & Forecast
      2. Saudi Arabia
         1. By Product Type
         2. By Applications
      3. South Africa
         1. By Product Type
         2. By Applications
      4. Kuwait
         1. By Product Type
         2. By Applications
      5. Rest of Middle East & Africa
         1. By Product Type
         2. By Applications
7. Company Profile
   1. CRISPR Therapeutics AG
      1. Company Overview
      2. Financial Performance
      3. Recent Developments
      4. Product Portfolio
   2. Thermo Fisher Scientific Inc
      1. Company Overview
      2. Financial Performance
      3. Recent Developments
      4. Product Portfolio
   3. Synthego Corporation
      1. Company Overview
      2. Financial Performance
      3. Recent Developments
      4. Product Portfolio
8. Conclusion & Recommendation
9. Acronyms & Abbreviations

Table of Content and Figure @ https://straitsresearch.com/report/crispr-gene-editing-market/toc

Recent Developments

• June 2022 - Agilent Technologies Inc., a global leader in genomics technology, Leverages NVIDIA and AWS Technology to Improve Analysis Speeds of Genomics Bioinformatics Pipelines and announced it will use Amazon Elastic Compute Cloud (Amazon EC2) G5g instances powered by Amazon Web Services (AWS) Graviton2 processors and featuring NVIDIA T4G Tensor Core GPUs, in combination with NVIDIA Clara Parabricks’ advanced genomics analysis capabilities, to significantly improve processing speeds for variant calling workflows on Agilent’s cloud-native Alissa Reporter software.
• October 2021 - Abcam, a global leader in the development of reagents and technologies for use in the life sciences industry, has announced the successful conclusion of its acquisition of BioVision and the expansion of its immunoassay capacity in Eugene, Oregon, scheduled to take place in October 2021.

News Media

How Next-Generation Robots Will Change Businesses?

How Could Gene Therapy Overcome Difficulties in Cancer Treatment

Have a Look at the Related Research Report

Neoantigen Cancer Vaccine Market: Information by Neoantigen Type (Synthetic Long Peptide, Tumour cell), Route of Administration (Intravenous, Transdermal), and Region — Forecast till 2030

Cancer Microbiome Sequencing Market: Information by Offering (Product, Service), End-User (Hospitals and Diagnostic Laboratories), and Region — Forecast till 2030

Genetic Testing Market: Information by Type (Carrier Testing, Diagnostic Testing), Technology (Cytogenetic Testing), Application (Cancer Diagnosis), and Region — Forecast till 2030

Ovarian Cancer Market: Information by Type (Epithelial Tumors), Diagnosis (Ultrasound), Therapeutic Treatment (Chemotherapy), Drugs (Mitotic Inhibitors), and Region — Forecast till 2030

About Straits Research Pvt. Ltd.

StraitsResearch is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-makers. Straits Research Pvt. Ltd. provides actionable market research data, especially designed and presented for decision making and ROI.

Whether you are looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with the client’s purchase. We overcome our clients’ issues by recognizing and deciphering the target group and generating leads with utmost precision. We seek to collaborate with our clients to deliver a broad spectrum of results through a blend of market and business research approaches.

For more information on your target market, please contact us below:

Phone: +1 646 480 7505 (the U.S.)

+91 8087085354 (APAC)

+44 208 068 9665 (the U.K.)

Email: sales@straitsresearch.com

Follow Us: LinkedIn | Facebook | Instagram | Twitter